ArticleScientific reports2026
TUBB2A related epilepsy: novel variants and genotype-phenotype correlation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Restoring the Balance: CRISPRa-Driven β-Tubulin Compensation as a Strategy for Tubulinopathy Treatment.International journal of molecular sciences · 2026Article
- Genotypic and phenotypic heterogeneity in tubulinopathies: insights from a Turkish multicenter cohort.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
This study delineated the clinical phenotypes of epilepsy patients harboring TUBB2A variants and explored the pathogenesis of novel variants in HEK293T cells. The clinical data of 5 epilepsy patients in our cohort and 23 epilepsy patients from published studies carrying TUBB2A variants were evaluated. TUBB2A-FLAG and TUBB2A-EGFP plasmids were constructed to investigate the functional implications of TUBB2A variants. In 28 patients with epilepsy, the seizure onset age spanned from neonatal period to 8 years old, with 61% experiencing seizures before 1-year-old. The prevalent seizure types were epileptic spasms (32%) and focal seizures (32%). All 28 patients showed varying degrees of developmental delay, and 93% had malformation of cortical development (MCD). All identified TUBB2A variants were missense variants. Three-dimensional structure predictions revealed that 83% of patients diagnosed with pachygyria possessed variants situated near or at the linkage of α-β tubulin. We investigated 4 novel variants and 4 reported variants and found that all 8 variants affected the morphology of spindle apparatus and dynamics of microtubules. Variants located at or near α-β tubulin dimer interface exerted a pronounced influence on the morphology and dynamic of microtubules. Most patients with TUBB2A-related epilepsy experience seizures before 1-year-old. Over 90% of these patients presented with MCDs, and all displayed varying degrees of developmental delay. Patients with TUBB2A variants that perturb tubulin dimer linkage were observed to have a higher proportion of severe phenotypes, such as pachygyria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.